These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4347721)

  • 21. The effects of bifunctional alkylating agents on DNA synthesis in sensitive and resistant Yoshida cells.
    Carr FJ; Fox BW
    Mutat Res; 1982 Aug; 95(2-3):441-56. PubMed ID: 7121494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. THE IN VITRO INDUCTION OF DRUG RESISTANCE OF YOSHIDA SARCOMA TO ANTITUMOR AGENTS.
    SAKURAI Y; MORIWAKI A
    Gan; 1963 Dec; 54():473-9. PubMed ID: 14099942
    [No Abstract]   [Full Text] [Related]  

  • 23. Isolation and characterization of nitrogen mustard-sensitive cells from a nitrogen mustard-resistant subline of Yoshida sarcoma.
    Isaka H; Izumitani M; Moriwaki A; Sakurai Y
    Gan; 1966 Aug; 57(4):353-66. PubMed ID: 5969489
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. XIV. Inhibiting effect of nitromin upon small number of Yoshida sarcoma cells. 3].
    ISHIDATE M; SAKURAI Y; YOSHIDA T; SATOH H
    Gan; 1956 Dec; 47(3-4):380-2. PubMed ID: 13415047
    [No Abstract]   [Full Text] [Related]  

  • 25. Collateral sensitivity between methylene dimethane sulfonate and halogenated methotrexate derivatives in the Yoshida sarcoma in vivo and in vitro.
    Fox BW
    J Natl Cancer Inst; 1977 Apr; 58(4):955-8. PubMed ID: 191629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibitory action of the chemical compounds which inhibit Yoshida sarcoma].
    TAZAKA S; ROKUJO T
    Gan; 1954 Sep; 45(2-3):541-3. PubMed ID: 13220980
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. XV. Determination of minimum effective dose of nitromin and other compounds by in vitro tests.
    ISHIDATE M; SAKURAI Y; YOSHIDA T; SATOH H
    Gan; 1956 Dec; 47(3-4):382-4. PubMed ID: 13415048
    [No Abstract]   [Full Text] [Related]  

  • 28. A study of growth of ascites hepatoma and Yoshida sarcoma in rats and changes caused by nitromin treatment.
    KONO O; TERASHIMA H; AZUMA S; MURATA Y
    Gan; 1954 Sep; 45(2-3):536-8. PubMed ID: 13220977
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytochemical characterization of Yoshida sarcoma cells resistant to dibromodulcitol.
    Gáti E; Pokorny E; Somfai-Relle S; Szentirmay Z
    Int J Tissue React; 1984; 6(1):43-51. PubMed ID: 6715118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. IV].
    ISHIDATE M; SAKURAI Y; YOSHIDA T; SATO H; SATOH H; MATUI E; IMAMURA H
    Gan; 1953 Sep; 44(2-3):342-6. PubMed ID: 13128187
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. III. The effect of N-oxide derivatives of nitrogen mustards].
    ISHIDATE M; SAKURAI Y; YOSHIDA T; SATO H; KOBAYASHI K
    Gan; 1952 Sep; 43(2-3):171-4. PubMed ID: 12998801
    [No Abstract]   [Full Text] [Related]  

  • 32. Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. IX. Effect of some new nitrogen mustards and their N-oxides.
    ISHIDATE M; SAKURAI Y; YOSHIDA T; SATOH H; IMAMURA H
    Gan; 1955 Sep; 46(2-3):475-80. PubMed ID: 13262461
    [No Abstract]   [Full Text] [Related]  

  • 33. Increase of adenosine triphosphatase activity of Yoshida sarcoma cells in the process of acquiring resistance to alkylating agents.
    Tsukagoshi S; Moriwaki A; Sakurai Y
    Gan; 1971 Feb; 62(1):65-6. PubMed ID: 4251851
    [No Abstract]   [Full Text] [Related]  

  • 34. Uptake studies of [14C] methylene dimethanesulphonate in bilaterally transplanted sensitive and resistant Yoshida sarcoma.
    Fox BW
    Chem Biol Interact; 1971 Jun; 3(3):149-56. PubMed ID: 5134988
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. V. Evaluation and comparison of curative effects of compounds tested using the diagram of percentage survival].
    ISHIDATE M; SAKURAI Y; YOSHIDA T; SATOH H; IMAMURA H
    Gan; 1954 Sep; 45(2-3):484-8. PubMed ID: 13220956
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental studies on chemotherapy of malignant growth employing Yoshida sarcoma animals. XVI. Determination of minimum effective dose (MED) of nitromin and other compounds by means of cytochemical detection of the PAS positive substances.
    SATO H; NOUCHI F; YOSHIDA T; ISHIDATE M
    Gan; 1957 Dec; 48(4):403-4. PubMed ID: 13524424
    [No Abstract]   [Full Text] [Related]  

  • 37. Differential effects of cytotoxic concentrations of chlorambucil on drug-resistant and drug-sensitive cell lines of the Yoshida ascites sarcoma in culture.
    Hill BT
    Eur J Cancer (1965); 1975 Jan; 11(1):91-6. PubMed ID: 1169147
    [No Abstract]   [Full Text] [Related]  

  • 38. A study on the effect of hyperbaric oxygenation on Yoshida sarcoma, especially on its influence on generation time.
    Osada T
    Nagoya J Med Sci; 1968 Sep; 31(2):243-76. PubMed ID: 5716339
    [No Abstract]   [Full Text] [Related]  

  • 39. Antitumor effectiveness of improsulfan on nitrogen mustard-resistant Yoshida sarcoma cells.
    Okumoto T; Sugimoto N; Imamura H
    Chem Pharm Bull (Tokyo); 1977 Nov; 25(11):3003-8. PubMed ID: 203408
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug resistance study in a mixed nitrogen mustard-sensitive-resistant tumour.
    Ujházy V
    Neoplasma; 1969; 16(4):467-8. PubMed ID: 5344233
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.